SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ARQT

Arcutis Biotherapeutics Inc.
NASDAQHealth Care

Latest close: 28.82 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 15, 2026Notice of sale · Form 144Howard Welgus · Director · $127.3KOpen the filing ↗
  2. Sep 16, 2026Reported sale · Form 4Masaru Matsuda, See Remarks · $91.9KOpen the filing ↗
  3. Sep 16, 2026Notice of sale · Form 144Larry Todd Edwards · Former Officer · $8.5MOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record82219 flagged findings
Reported transactions (Form 4)80since Nov 20, 2025 · and 14 other holdings
Corporate events (8-K)29since Apr 27, 2020

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-08-05share offering or dilution eventfreshOpen filing ↗
    “…In October 2025, certain pre-funded warrants were exercised, resulting in the issuance of 2,285,000 shares. As of June 30, 2026,…”
    +1 more passage from the same document
    • “…(ATM) Offerings On May 6, 2021, the Company entered into a sales agreement (Sales Agreement) with Cowen and Company, LLC…”
  • 2026-05-06share offering or dilution eventrecentOpen filing ↗
    “…In October 2025, certain prefunded warrants were exercised, resulting in the issuance of 2,285,000 shares. As of March 31, 2026,…”
    +1 more passage from the same document
    • “…(ATM) Offerings On May 6, 2021, the Company entered into a sales agreement (Sales Agreement) with Cowen and Company, LLC…”
  • 2026-05-06capital return (buybacks/dividends)recentOpen filing ↗
    “…number of common share equivalents outstanding for the period determined using the treasury-stock method. Since the…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 822)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 15, 26Form 144 ↗Notice of proposed sale new
  • Oct 5, 26SCHEDULE 13G/A ↗Passive stake · BlackRock, Inc. · 14.1% · event on Sep 30, 26 · amendment
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Notice of proposed sale · 2 Form 144 filingsshow all 2hide
  • Sep 10, 26Form 4 ↗Insider transaction
  • Sep 8, 26Form 144 ↗Notice of proposed sale
  • Aug 28, 26Form 4 ↗Insider transaction
  • Aug 27, 26Form 144 ↗Notice of proposed sale
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Aug 20, 26Form 144 ↗Notice of proposed sale
  • Aug 19, 26Form 4 ↗Insider transaction
  • Notice of proposed sale · 2 Form 144 filingsshow all 2hide
  • Aug 14, 26SCHEDULE 13G ↗Passive stake · Polar Capital Holdings Plc · 5.3% · event on Jun 30, 26
  • Aug 13, 26Form 4 ↗Insider transaction
  • Aug 11, 26Form 144 ↗Notice of proposed sale
  • Aug 7, 26SCHEDULE 13G ↗Passive stake · STATE STREET CORPORATION · 4.7% · event on Jun 30, 26
  • Aug 5, 2610-Q ↗Quarterly report
  • Aug 5, 268-K ↗Current report · A senior executive left or was appointed
  • Insider transaction · 3 Form 4 filingsshow all 3hide

822 filings on record, the oldest from Oct 7, 19.

Listing the 25 most recent filings of the 822 on record.

8-Ks, explained

Structure12Governance17
  • Governance5 senior executive changes2024 – 2026show all 5hide
    • Aug 5, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jul 16, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Dec 8, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Apr 10, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Apr 10, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Feb 28, 24StructureEntered a material agreement8-K 1.01 ↗
  • Governance4 senior executive changes2023 – 2024show all 4hide
    • Feb 15, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Sep 27, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Sep 7, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K/A 5.02 ↗
    • Aug 18, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Aug 14, 23StructureEntered a material agreement8-K 1.01 ↗
  • May 24, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Sep 7, 22StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Sep 6, 22GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Aug 2, 22StructureTook on a new financial obligation+2 more in the same filing8-K 2.03 ↗
  • Dec 23, 21StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Sep 28, 21StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Governance3 senior executive changes2021show all 3hide
    • Sep 7, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jun 14, 21GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Mar 26, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jan 15, 21StructureEntered a material agreement8-K 1.01 ↗

5 older filings not shown

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Patrick J. Heron7.5%Aug 18, 25SCHEDULE 13D/A ↗20 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • BlackRock, Inc.14.1%Sep 30, 26SCHEDULE 13G/A ↗
  • Rubric Capital Management LP6.8%Dec 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Polar Capital Holdings Plc5.3%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • STATE STREET CORPORATION4.7%Jun 30, 26SCHEDULE 13G ↗1 earlier filing
  • PRUDENTIAL FINANCIAL INC4.3%Mar 31, 26SCHEDULE 13G/A ↗2 earlier filings
show one more holderhide

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Oct 15, Howard Welgus filed notice of intent to sell up to $127K. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

No sale of theirs is on record yet in Form 4; the 90-day window is still open.

View notice (Form 144) ↗+9 more recent notices · 8 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 16, 26Sell$92KMasaru MatsudaSee Remarks↗
  • Sep 15, 26Sell$114KHoward G. Welgus↗
  • Sep 8, 26Sell$250KMasaru MatsudaSee Remarks↗
  • Aug 27, 26Sell$279KTerrie Curran↗
  • Aug 27, 26Sell$677KTerrie Curran↗
  • Aug 20, 26Sell$28KTerrie Curran↗
  • Aug 19, 26Sell$46KPatrick BurnettSee Remarks↗
  • Aug 17, 26Sell$124KHoward G. Welgus↗
  • Aug 12, 26Sell$175KPatrick BurnettSee Remarks↗
  • Aug 11, 26Sell$220KPatrick BurnettSee Remarks↗
  • Aug 3, 26Sell$114KTodd WatanabeSee Remarks↗
  • Aug 3, 26Sell$32KMasaru MatsudaSee Remarks↗

There are 5 more transactions in this stretch.

Stock compensation, tax and giftsshow the 23 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 15, 26Compensation$5KHoward G. Welgus↗
  • Sep 15, 26Compensation$8KHoward G. Welgus↗
  • Sep 15, 26Compensation$19KHoward G. Welgus↗
  • Aug 27, 26Compensation$84KTerrie Curran↗
  • Aug 27, 26Compensation$233KTerrie Curran↗
  • Aug 20, 26Compensation$8KTerrie Curran↗
  • Aug 17, 26Compensation$5KHoward G. Welgus↗
  • Aug 17, 26Compensation$8KHoward G. Welgus↗
  • Aug 17, 26Compensation$19KHoward G. Welgus↗
  • Aug 12, 26Compensation$24KPatrick BurnettSee Remarks↗
  • Aug 11, 26Compensation$30KPatrick BurnettSee Remarks↗
  • Jul 15, 26Compensation$5KHoward G. Welgus↗
  • Jul 15, 26Compensation$8KHoward G. Welgus↗
  • Jul 15, 26Compensation$19KHoward G. Welgus↗
  • Jul 15, 26Compensationamount n/aChristopher Peetz↗
  • Jun 15, 26Compensation$5KHoward G. Welgus↗
  • Jun 15, 26Compensation$8KHoward G. Welgus↗
  • Jun 15, 26Compensation$19KHoward G. Welgus↗
  • Jun 5, 26Compensationamount n/aNeha Krishnamohan↗
  • Jun 5, 26Compensationamount n/aHalley E Gilbert↗
  • Jun 5, 26Compensationamount n/aAmit Munshi↗
  • Jun 5, 26Compensationamount n/aTerrie Curran↗
  • Jun 5, 26Compensationamount n/aKeith R Leonard↗

The full record holds 371 transactions and goes back to Aug 18, 22.

Its sector and its market

Arcutis Biotherapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Arcutis Biotherapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Arcutis Biotherapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
822 documents on file, from Oct 7, 2019 to Oct 15, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.